{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:59:30Z","timestamp":1792425570541,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005220","name":"Agency for Toxic Substances and Disease Registry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002576","name":"American Cyronics Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.envres.2025.122381","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T15:17:58Z","timestamp":1752938278000},"page":"122381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"P3","title":["A case-cohort study of the association between per- and polyfluoroalkyl substances (PFAS) and breast cancer among participants in the American Cancer Society\u2019s Cancer Prevention Study-II"],"prefix":"10.1016","volume":"285","author":[{"given":"Shamim","family":"Shahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7258-3215","authenticated-orcid":false,"given":"Andrea","family":"Winquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1564-3642","authenticated-orcid":false,"given":"Alyssa N.","family":"Troeschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5418-9000","authenticated-orcid":false,"given":"W. Ryan","family":"Diver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6253-7394","authenticated-orcid":false,"given":"James M.","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Deubler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpa V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1471-5608","authenticated-orcid":false,"given":"Christina C.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2419-8536","authenticated-orcid":false,"given":"Lauren R.","family":"Teras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.envres.2025.122381_bib70","unstructured":"American Cancer Society, 2024. Key statistics for breast cancer. https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/about\/how-common-is-breast-cancer.html (accessed 28 May 2024)."},{"issue":"4","key":"10.1016\/j.envres.2025.122381_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/EDE.0b013e31821d0879","article-title":"Left truncation, susceptibility, and bias in occupational cohort studies","volume":"22","author":"Applebaum","year":"2011","journal-title":"Epidemiology"},{"issue":"12","key":"10.1016\/j.envres.2025.122381_bib3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0895-4356(99)00102-X","article-title":"Analysis of case-cohort designs","volume":"52","author":"Barlow","year":"1999","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.envres.2025.122381_bib4","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.fertnstert.2015.02.001","article-title":"Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women","volume":"103","author":"Barrett","year":"2015","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.envres.2025.122381_bib5","first-page":"1439","article-title":"Breast cancer risk after exposure to perfluorinated compounds in Danish women: a case\u2013control study nested in the Danish national birth cohort","volume":"25","author":"Bonefeld-J\u00f8rgensen","year":"2014","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.envres.2025.122381_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr2245","article-title":"Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem\/progenitor cells","volume":"11","author":"Britt","year":"2009","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.envres.2025.122381_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ieam.258","article-title":"Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins","volume":"7","author":"Buck","year":"2011","journal-title":"Integrated Environ. Assess. Manag."},{"key":"10.1016\/j.envres.2025.122381_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2021.116619","article-title":"Associations of exposure to perfluoroalkyl substances individually and in mixtures with persistent infections: recent findings from NHANES 1999\u20132016","volume":"275","author":"Bulka","year":"2021","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.envres.2025.122381_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2019.105048","article-title":"Legacy and alternative per-and polyfluoroalkyl substances in the US general population: paired serum-urine data from the 2013\u20132014 national health and nutrition examination survey","volume":"131","author":"Calafat","year":"2019","journal-title":"Environ. Int."},{"issue":"2","key":"10.1016\/j.envres.2025.122381_bib10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/cncr.10197","article-title":"The American cancer society cancer prevention study II nutrition cohort: rationale, study design, and baseline characteristics","volume":"94","author":"Calle","year":"2002","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.envres.2025.122381_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ijc.34487","article-title":"Serum perfluorooctane sulfonate and perfluorooctanoate and risk of postmenopausal breast cancer according to hormone receptor status: an analysis in the prostate, lung, colorectal and ovarian cancer screening trial","volume":"153","author":"Chang","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.envres.2025.122381_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/aje\/kwae010","article-title":"Exposure to per-and polyfluoroalkyl substances and breast cancer risk: a systematic review and meta-analysis of epidemiologic studies","author":"Chang","year":"2024","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.envres.2025.122381_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12940-022-00958-5","article-title":"Consideration of pathways for immunotoxicity of per-and polyfluoroalkyl substances (PFAS)","volume":"22","author":"Ehrlich","year":"2023","journal-title":"Environ. Health"},{"key":"10.1016\/j.envres.2025.122381_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2022.119345","article-title":"Plasma perfluoroalkyl substance exposure and incidence risk of breast cancer: a case-cohort study in the dongfeng-tongji cohort","volume":"306","author":"Feng","year":"2022","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.envres.2025.122381_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2019.105324","article-title":"Albumin is the major carrier protein for PFOS, PFOA, PFHxS, PFNA and PFDA in human plasma","volume":"137","author":"Forsthuber","year":"2020","journal-title":"Environ. Int."},{"issue":"3","key":"10.1016\/j.envres.2025.122381_bib18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"issue":"4","key":"10.1016\/j.envres.2025.122381_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104020","article-title":"Implications of PFAS definitions using fluorinated pharmaceuticals","volume":"25","author":"Hammel","year":"2022","journal-title":"iScience"},{"issue":"20","key":"10.1016\/j.envres.2025.122381_bib20","doi-asserted-by":"crossref","first-page":"14594","DOI":"10.1021\/acs.est.2c02660","article-title":"Targeted and suspect screening of per-and polyfluoroalkyl substances in cosmetics and personal care products","volume":"56","author":"Harris","year":"2022","journal-title":"Environ. Sci. Technol."},{"issue":"4","key":"10.1016\/j.envres.2025.122381_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jat.1736","article-title":"Comparison of in vitro cytotoxicity, estrogenicity and anti\u2010estrogenicity of triclosan, perfluorooctane sulfonate and perfluorooctanoic acid","volume":"33","author":"Henry","year":"2013","journal-title":"J. Appl. Toxicol."},{"issue":"6","key":"10.1016\/j.envres.2025.122381_bib22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/EDE.0b013e3181875e61","article-title":"Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease","volume":"19","author":"Hern\u00e1n","year":"2008","journal-title":"Epidemiology"},{"key":"10.1016\/j.envres.2025.122381_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12940-018-0426-6","article-title":"Breast cancer risk and serum levels of per-and poly-fluoroalkyl substances: a case-control study nested in the California teachers study","volume":"17","author":"Hurley","year":"2018","journal-title":"Environ. Health"},{"issue":"4","key":"10.1016\/j.envres.2025.122381_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/toxics8040125","article-title":"The confounder-mediator dilemma: should we control for obesity to estimate the effect of perfluoroalkyl substances on health outcomes?","volume":"8","author":"Inoue","year":"2020","journal-title":"Toxics"},{"key":"10.1016\/j.envres.2025.122381_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.149316","article-title":"Serum perfluoroalkyl substances and breast cancer risk in Japanese women: a case-control study","volume":"800","author":"Itoh","year":"2021","journal-title":"Sci. Total Environ."},{"issue":"5","key":"10.1016\/j.envres.2025.122381_bib26","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1681\/ASN.2007060712","article-title":"Association of albuminuria and cancer incidence","volume":"19","author":"J\u00f8rgensen","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.envres.2025.122381_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-069X-13-116","article-title":"Perfluoroalkyl substances and time to pregnancy in couples from Greenland, Poland and Ukraine","volume":"13","author":"J\u00f8rgensen","year":"2014","journal-title":"Environ. Health"},{"key":"10.1016\/j.envres.2025.122381_bib28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fonc.2016.00228","article-title":"Potential mechanisms underlying the protective effect of pregnancy against breast cancer: a focus on the IGF pathway","volume":"6","author":"Katz","year":"2016","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.envres.2025.122381_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw276","article-title":"Risk factors that increase risk of estrogen receptor\u2013positive and\u2013negative breast cancer","volume":"109","author":"Kerlikowske","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.envres.2025.122381_bib30","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1210\/jc.2010-2401","article-title":"Implications of early menopause in women exposed to perfluorocarbons","volume":"96","author":"Knox","year":"2011","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/j.envres.2025.122381_bib31","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/toxsci\/kfm128","article-title":"Perfluoroalkyl acids: a review of monitoring and toxicological findings","volume":"99","author":"Lau","year":"2007","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.envres.2025.122381_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12940-022-00895-3","article-title":"Perfluoroalkyl substances (PFASs) as risk factors for breast cancer: a case\u2013control study in Chinese population","volume":"21","author":"Li","year":"2022","journal-title":"Environ. Health"},{"issue":"4","key":"10.1016\/j.envres.2025.122381_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.aquatox.2007.09.009","article-title":"Evaluation of estrogenic activities and mechanism of action of perfluorinated chemicals determined by vitellogenin induction in primary cultured tilapia hepatocytes","volume":"85","author":"Liu","year":"2007","journal-title":"Aquat. Toxicol."},{"issue":"7","key":"10.1016\/j.envres.2025.122381_bib34","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.envint.2011.05.001","article-title":"Comparison on gestation and lactation exposure of perfluorinated compounds for newborns","volume":"37","author":"Liu","year":"2011","journal-title":"Environ. Int."},{"key":"10.1016\/j.envres.2025.122381_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10911-013-9275-7","article-title":"Endocrine disruptors and the breast: early life effects and later life disease","volume":"18","author":"Macon","year":"2013","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"4","key":"10.1016\/j.envres.2025.122381_bib36","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/ijc.32357","article-title":"Perfluorinated alkylated substances serum concentration and breast cancer risk: evidence from a nested case\u2010control study in the French E3N cohort","volume":"146","author":"Mancini","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.envres.2025.122381_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1289\/ehp.1306613","article-title":"Breastfeeding: a potential excretion route for mothers and implications for infant exposure to perfluoroalkyl acids","volume":"122","author":"Mondal","year":"2014","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envres.2025.122381_bib15","unstructured":"Environmental Protection Agency, 2025. Key EPA actions to address PFAS. https:\/\/www.epa.gov\/pfas\/key-epa-actions-address-pfas (accessed 25 July 2025)."},{"key":"10.1016\/j.envres.2025.122381_bib71","unstructured":"National Academies of Sciences, Engineering, and Medicine, 2012. Breast cancer and the environment: A life course approach. The National Academies Press, Washington, DC. https:\/\/nap.nationalacademies.org\/catalog\/13263\/breast-cancer-and-the-environment-a-life-course-approach (accessed 28 May 2024)."},{"key":"10.1016\/j.envres.2025.122381_bib38","unstructured":"National Academies of Sciences, Engineering, and Medicine, 2022. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. The National Academies Press, Washington, DC. https:\/\/nap.nationalacademies.org\/catalog\/26156\/guidance-on-pfas-exposure-testing-and-clinical-follow-up (accessed 25 July 2025)."},{"issue":"9","key":"10.1016\/j.envres.2025.122381_bib39","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1289\/ehp.10009","article-title":"Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers","volume":"115","author":"Olsen","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envres.2025.122381_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.110329","article-title":"A cross-sectional study of the association between perfluorinated chemical exposure and cancers related to deregulation of estrogen receptors","volume":"196","author":"Omoike","year":"2021","journal-title":"Environ. Res."},{"key":"10.1016\/j.envres.2025.122381_bib45","series-title":"Monograph on Immunotoxicity Associated with Exposure to Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS)","author":"National Toxicology Program (NTP)","year":"2016"},{"issue":"3","key":"10.1016\/j.envres.2025.122381_bib41","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/EDE.0000000000001469","article-title":"The case for case\u2013cohort: an applied epidemiologist's guide to reframing case\u2013cohort studies to improve usability and flexibility","volume":"33","author":"O'Brien","year":"2022","journal-title":"Epidemiology"},{"issue":"4","key":"10.1016\/j.envres.2025.122381_bib42","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/biomet\/82.4.669","article-title":"Causal diagrams for empirical research","volume":"82","author":"Pearl","year":"1995","journal-title":"Biometrika"},{"issue":"2","key":"10.1016\/j.envres.2025.122381_bib43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/028418600430699","article-title":"Increased urinary albumin excretion rate in breast cancer patients","volume":"39","author":"Pedersen","year":"2000","journal-title":"Acta Oncol."},{"issue":"1","key":"10.1016\/j.envres.2025.122381_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/biomet\/73.1.1","article-title":"A case-cohort design for epidemiologic cohort studies and disease prevention trials","volume":"73","author":"Prentice","year":"1986","journal-title":"Biometrika"},{"issue":"9","key":"10.1016\/j.envres.2025.122381_bib46","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.envres.2025.122381_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.153031","article-title":"Per-and poly-fluoroalkyl substances (PFAS) and female reproductive outcomes: PFAS elimination, endocrine-mediated effects, and disease","volume":"465","author":"Rickard","year":"2022","journal-title":"Toxicology"},{"key":"10.1016\/j.envres.2025.122381_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr1029","article-title":"The protective role of pregnancy in breast cancer","volume":"7","author":"Russo","year":"2005","journal-title":"Breast Cancer Res."},{"issue":"6","key":"10.1016\/j.envres.2025.122381_bib49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/1940-6207.CAPR-23-0138","article-title":"Reproductive events and risk of women's cancers: from parturition to prevention","volume":"16","author":"Sherman","year":"2023","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.envres.2025.122381_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-8-70","article-title":"Reducing bias through directed acyclic graphs","volume":"8","author":"Shrier","year":"2008","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.envres.2025.122381_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-072X-10-32","article-title":"Estrogen receptor positive breast cancers and their association with environmental factors","volume":"10","author":"St-Hilaire","year":"2011","journal-title":"Int. J. Health Geogr."},{"key":"10.1016\/j.envres.2025.122381_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.110690","article-title":"PFAS and cancer, a scoping review of the epidemiologic evidence","volume":"194","author":"Steenland","year":"2021","journal-title":"Environ. Res."},{"issue":"2","key":"10.1016\/j.envres.2025.122381_bib53","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41370-018-0094-1","article-title":"A review of the pathways of human exposure to poly-and perfluoroalkyl substances (PFASs) and present understanding of health effects","volume":"29","author":"Sunderland","year":"2019","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"issue":"6","key":"10.1016\/j.envres.2025.122381_bib13","first-page":"1887","article-title":"Robust causal inference using directed acyclic graphs: the R package \u2018dagitty","volume":"45","author":"Textor","year":"2016","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.envres.2025.122381_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2024.119560","article-title":"A case-cohort study of per-and polyfluoroalkyl substance concentrations and incident prostate cancer in the cancer prevention Study-II LifeLink cohort study","volume":"259","author":"Troeschel","year":"2024","journal-title":"Environ. Res."},{"key":"10.1016\/j.envres.2025.122381_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105850","article-title":"A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women","volume":"142","author":"Tsai","year":"2020","journal-title":"Environ. Int."},{"issue":"1","key":"10.1016\/j.envres.2025.122381_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40572-022-00332-0","article-title":"An epidemiologic review of menstrual blood loss as an excretion route for per-and polyfluoroalkyl substances","volume":"9","author":"Upson","year":"2022","journal-title":"Curr. Environ. Health Rep."},{"key":"10.1016\/j.envres.2025.122381_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2021.131545","article-title":"Elevated levels of perfluoroalkyl substances in breast cancer patients within the greater manila area","volume":"286","author":"Velarde","year":"2022","journal-title":"Chemosphere"},{"issue":"3","key":"10.1016\/j.envres.2025.122381_bib58","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1289\/ehp.1205829","article-title":"Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis","volume":"121","author":"Vieira","year":"2013","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.envres.2025.122381_bib59","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.envint.2014.04.013","article-title":"Global emission inventories for C4\u2013C14 perfluoroalkyl carboxylic acid (PFCA) homologues from 1951 to 2030, part I: production and emissions from quantifiable sources","volume":"70","author":"Wang","year":"2014","journal-title":"Environ. Int."},{"key":"10.1016\/j.envres.2025.122381_bib60","article-title":"Immunosenescence, aging and successful aging","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.envres.2025.122381_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.114718","article-title":"The effects of perfluoroalkyl and polyfluoroalkyl substances on female fertility: a systematic review and meta-analysis","volume":"216","author":"Wang","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.envres.2025.122381_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12940-017-0269-6","article-title":"Serum levels of environmental pollutants is a risk factor for breast cancer in Inuit: a case control study","volume":"16","author":"Wiels\u00f8e","year":"2017","journal-title":"Environ. Health"},{"issue":"12","key":"10.1016\/j.envres.2025.122381_bib63","doi-asserted-by":"crossref","DOI":"10.1289\/EHP13174","article-title":"Case\u2013cohort study of the association between PFAS and selected cancers among participants in the American cancer society's cancer prevention study II LifeLink cohort","volume":"131","author":"Winquist","year":"2023","journal-title":"Environ. Health Perspect."},{"issue":"15","key":"10.1016\/j.envres.2025.122381_bib64","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1021\/es500796y","article-title":"Enhanced elimination of perfluorooctane sulfonic acid by menstruating women: evidence from population-based pharmacokinetic modeling","volume":"48","author":"Wong","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.envres.2025.122381_bib65","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.scitotenv.2017.10.074","article-title":"Association of serum levels of perfluoroalkyl substances (PFASs) with the metabolic syndrome (MetS) in Chinese male adults: a cross\u2013sectional study","volume":"621","author":"Yang","year":"2018","journal-title":"Sci. Total Environ."},{"issue":"1","key":"10.1016\/j.envres.2025.122381_bib66","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1470-2045(23)00622-8","article-title":"Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid","volume":"25","author":"Zahm","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.envres.2025.122381_bib67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.envpol.2011.09.001","article-title":"The inventory of sources, environmental releases and risk assessment for perfluorooctane sulfonate in China","volume":"165","author":"Zhang","year":"2012","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.envres.2025.122381_bib68","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1007\/s11356-014-3725-7","article-title":"PFOS and PFOA in paired urine and blood from general adults and pregnant women: assessment of urinary elimination","volume":"22","author":"Zhang","year":"2015","journal-title":"Environ. Sci. Pollut. Control Ser."},{"issue":"2","key":"10.1016\/j.envres.2025.122381_bib69","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2006.11.039","article-title":"Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis","volume":"49","author":"Zhu","year":"2007","journal-title":"Am. J. Kidney Dis."}],"container-title":["Environmental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013935125016329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013935125016329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T09:29:30Z","timestamp":1779614970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013935125016329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":70,"alternative-id":["S0013935125016329"],"URL":"https:\/\/doi.org\/10.1016\/j.envres.2025.122381","relation":{},"ISSN":["0013-9351"],"issn-type":[{"value":"0013-9351","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case-cohort study of the association between per- and polyfluoroalkyl substances (PFAS) and breast cancer among participants in the American Cancer Society\u2019s Cancer Prevention Study-II","name":"articletitle","label":"Article Title"},{"value":"Environmental Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.envres.2025.122381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"122381"}}